NeuroImage: Clinical, 40, 103503
[9] According to the FDA prescribing information, nausea occurred in 12-24% of patients, vomiting in 2-11%, and diarrhea in 7-17%, with rates varying by dose (5 mg, 10 mg, or 15 mg weekly)
Prescribers set the pharmacologic plan, but outcomes are built by the entire team
The multidistrict litigation (MDL) was created after dozens of people filed lawsuits after they allegedly developed severe gastrointestinal complications from taking Mounjaro or another GLP-1 product
Serum potassium levels should be routinely assessed due to the risk of hyperkalemia, particularly in those using potassium-sparing diuretics or supplements
Zuyta iga moe zwiksza ryzyko zakaenia, powodowa bl podczas wkucia oraz utrudnia prawidowe podanie preparatu